Longevity Klotho Neuro moves to acquire Turn Bio assetsBy adminOctober 2, 20250 Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. Longevity-focused biotech Klotho Neurosciences revealed it…
DNA & Genetics Yokogawa and Repligen Partner to Enhance Process Analytical Technology – Automated bioprocess control with integration of OpreX Bio Pilot and MAVERICKBy adminSeptember 16, 20250 Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa’s OpreX Bio Pilot with Repligen’s MAVERICK ® ,…
